Efficacy and safety of Shexiang Baoxin Pill for stable coronary artery disease: A systematic review and meta-analysis of 42 randomized controlled trials

• Main Authors: Jingjing Wei (Author), Teng Ma (Author), Cheng Zhou (Author), Pengle Hao (Author), Bin Li (Author), Xinlu Wang (Author), Rui Yu (Author), Mingjun Zhu (Author), Yongxia Wang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: Patients with stable coronary artery disease (SCAD) still have a higher risk of adverse cardiovascular events. Shexiang Baoxin Pill (SBP) is widely used as a complementary and alternative treatment for SCAD. This study aimed to further verify the therapeutic effect and safety of SBP on SC...